Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multicountry study

J. P. Zellweger, A. Blaziene, C. Astbury, A. Hider (Lausanne, Switzerland; Vilnius, Lithuania; Greenford, United Kingdom)

Source: Annual Congress 2001 - Smoking cessation: efficacy of interventions
Session: Smoking cessation: efficacy of interventions
Session type: Poster Discussion
Number: 1117
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. P. Zellweger, A. Blaziene, C. Astbury, A. Hider (Lausanne, Switzerland; Vilnius, Lithuania; Greenford, United Kingdom). Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multicountry study. Eur Respir J 2001; 16: Suppl. 31, 1117

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study
Source: Eur Respir J 2001; 18: Suppl. 33, 12s
Year: 2001

Bupropion hydrochloride (Zyban™) is effective and well tolerated as an aid to smoking cessation - a multicountry study
Source: Eur Respir J 2001; 18: Suppl. 33, 11s
Year: 2001

Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease. 12 month follow-up phase data (ZYB40014)
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking
Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers
Year: 2013


The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies
Source: Eur Respir J 2002; 20: Suppl. 38, 579s
Year: 2002

Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015



Effectiveness of varenicline as an aid to smoking cessation in primary care: An observational study
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012


Efficacy of varenicline among smokers enrolled on a public health tobacco control program (HM-TCP) in the real-life setting
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015



Financial incentives combined with a smoking cessation group training programme increase abstinence rates in employees: a cluster randomized trial
Source: International Congress 2018 – Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use
Year: 2018



Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Intervention study to evaluate effectiveness of integrated therapy (varenicline plus montivational interviewing) for smoking cessation in diabetic patients:
Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake
Year: 2012



Cost effectiveness of inpatient initiated varenicline tartrate (VT) plus counselling compared to counselling alone: 2 year follow-up of the Smoking Termination Opportunity for inPatients (STOP) study
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016


A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Varenicline x combination of nicotine patch and bupropione: results of a smoking cessation private program
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Abstinence and effectiveness of smoking cessation project: experiences of Indian cancer NGO about predictable factors
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Pre-post pilot study of a one day smoking cessation training for health care professionals in charge with high risk smokers
Source: International Congress 2018 – Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes
Year: 2018

Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007


Efficacy of Zyban as smoking cessation aid for medical staff
Source: Eur Respir J 2001; 18: Suppl. 33, 447s
Year: 2001

Adolescents welcome the first Romanian pilot program to provide them smoking cessation - impact on recruitment
Source: Eur Respir J 2005; 26: Suppl. 49, 154s
Year: 2005

Patients perceptions of nicotine replacement therapy (NRT) and smoking cessation services available in their area
Source: Eur Respir J 2001; 18: Suppl. 33, 167s
Year: 2001